How much medical progress can we afford? Equity and the cost of health care.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Daniel Callahan.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The field of bioethics arose in the late 1960s in response to the emerging ethical dilemmas of that era. The field for many years focused in general on the dilemmas generated by high-technology medicine rather than on issues of population health and the ethical problems of public health programs and regulations. The time has come to more fully integrate the ethical problems of public health into the field of public health and, at the same time, into the field of bioethics. Public health raises a number of moral problems that extend beyond the earlier boundaries of bioethics and require their own form of ethical analysis.
The Hastings Center was founded in 1969 to study ethical problems in medicine and biology. The Center arose from a confluence of three social currents: the increased public scrutiny of medicine and its practices, the concern about the moral problems being generated by technological developments, and the desire of one its founders (Callahan) to make use of his philosophical training in a more applied way. The early years of the Center were devoted to raising money, developing an early agenda of issues, and identifying a cadre of people around the country interested in the issues. Various stresses and strains in the Center and the field are identified, and some final reflections are offered on the nature and value of the contributions made by bioethics as an academic field.
As with two storm systems colliding, one of the great health care struggles over the next few decades will be the clash between the demands of policy to reform the Medicare program in order to manage its growing costs and the ever improving but usually expensive clinical care that can now be provided to elderly patients. The extension to the elderly of surgical and other forms of treatment once thought impossible, and the antiageist triumph that extension symbolizes, is a remarkable triumph for medical progress. But managing the costs of that triumph has yet to be mastered, portending a rationing of high technology medicine for the elderly in the years to come. Fortunately, improved living standards and public health are likely to see better health for the elderly even if there is a limitation of expensive technologies. (c)1999 by CVRR, Inc.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A response to a critique by Roger W. Hunt of my views on the eventual likely need to use age as a standard for the allocation of expensive, high-technology, life-extending medical care for the elderly. The response encompasses three elements: 1. that while the elderly have a substantial claim to publicly-provided health care, it cannot be an unlimited claim; 2. that a health care system which provided a decent, coherent set of medical and social services for the elderly would be sufficient, even if some limits had to be set; and 3. allocation and rationing decisions should not be made by individual doctors at the bedside but by regional or national policy.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.